Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features
- 19 April 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 167 (1) , 91-97
- https://doi.org/10.1016/s0304-3835(01)00431-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prognostic impact of p21/waf1/cip1 in colorectal cancerInternational Journal of Cancer, 2000
- Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotypeProceedings of the National Academy of Sciences, 2000
- Chromosomal aberrations in PARP −/− mice: Genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNAProceedings of the National Academy of Sciences, 1999
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999
- Splitting the ATM: distinct repair and checkpoint defects in ataxia–telangiectasiaTrends in Genetics, 1998
- Urea improves efficiency of bisulphite-mediated sequencing of 5'- methylcytosine in genomic DNANucleic Acids Research, 1998
- 5-Fluorouracil in colorectal cancer: rationale and clinical results of frequently used schedulesAnti-Cancer Drugs, 1998
- Mutation of the transforming growth factor-β type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterationsThe Journal of Pathology, 1998
- Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)Nucleic Acids Research, 1997
- Function and Regulation of the Human Multidrug Resistance GenePublished by Elsevier ,1992